Indirect measurement of tissue analytes through tissue properties
CA 2471564 A1 · Owner: Sensys Medical, Inc. · Inventors: Thennadil, Suresh N.; Lorenz, Alexander D.; Hazen, Kevin H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and system for noninvasive determination of tissue analytes utilize tissue, properties as reflected in key features of an analytical signal to improve measurement, accuracy and precision. Physiological conditions such as changes in water distribution among tissue compartments lead to complex alterations in the measured, analytical signal of skin, leading to a biased noninvasive analyte measurement. Changes in the tissue properties are detected by identifying key features in the, analytical signal responsive to physiological variations. Conditions not conducive to, the noninvasive measurement are detected. Noninvasive measurements that are biased by physiological changes in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.